Skip to content
Digital Varden

Zimbabwe Rejects ‘Unbalanced’ US Healthcare Assistance Agreement Over Information Concerns

Medical funding illustration
The proposed American financial assistance would have supported initiatives for treating and preventing HIV/Aids, tuberculosis, and malaria.

Zimbabwe has turned down a major American health deal valued at $367m (£272m) spanning five years because of Washington's request for sensitive biological samples.

The decision came to light after a internal memorandum from December was leaked, indicating that President Emmerson Mnangagwa believed the arrangement was "lopsided".

An official spokesperson later stated that the US was requesting health data for research and commercial purposes but was not willing to share the resulting advantages from any future vaccines.

"We are forced to start the challenging and unfortunate task of ending our health assistance in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont publicly.

The US Embassy indicated the United States had provided more than $1.9bn in health funding to Zimbabwe during the past twenty years.

A physicians' group in Zimbabwe has called for continued negotiations to find a agreement suitable to all parties so the country's vital HIV programme can be sustained.

Wider Background

This rejection comes after a similar case in Kenya, where a high court blocked a related health funding agreement after concerns were raised about the safety of citizens' health data.

Since resuming office recently, US President Donald Trump has slashed foreign aid and shut down the key foreign aid agency.

The agency had managed aid for the US government, but Trump claimed its spending was "inefficient" and his administration was pursuing government-to-government deals to boost openness and responsibility.

According to statements, 16 nations in Africa have so far agreed to these new agreements, constituting over $18.3bn in new funding.

Specifics of the Declined Agreement

The money for Zimbabwe was intended to funded "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".

"It is our view this partnership might have yielded significant benefits for the people of Zimbabwe, particularly the 1.2 million men, women and children currently receiving HIV treatment through US-supported initiatives," the Ambassador added.

However, official spokesman Nick Mangwana maintained the arrangement was "unequal".

"Zimbabwe was being asked to share its genetic material and health information for a long time, without any equivalent promise of benefiting from any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that might be developed from that shared data," his statement read.

"In essence, our country would provide the basic resources for medical research with no certainty that the final treatments would be available to our people should a new pandemic emerge."

Sovereignty and International Frameworks

He also noted that the US's withdrawal from the World Health Organization (WHO) and its pursuit of one-on-one deals were upending structures previously set up through the global organization.

Mangwana cited its Pandemic Benefit-Sharing scheme created to manage potential global health emergencies.

"This mechanism is intended to ensure that when a nation provides its data, the resulting advantages – such as medicines and cures – are shared equitably, not monopolised solely by those with the resources to develop them."

These objections over the US deal "are not meant as opposition to America," he added.

"We encourage further dialogue with our US partners on how future co-operation might be structured in a manner that honours the independence and interests of each country."

Health Experts Reaction

The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it recognised the government's concerns, but urged that negotiations need to persist given that a large portion of the nation's Aids initiatives depended on foreign aid.

"If technical issues arise, such as those involving information security or agreement terms, these can frequently be addressed through technical clarification and negotiated safeguards," the group commented.

This impasse highlights the ongoing tensions between receiving crucial international aid and protecting national sovereignty in an ever more data-driven world.

Written by

Jessica Holloway

A digital strategist with over a decade of experience in SEO and content marketing, passionate about helping businesses thrive online.

Digital Varden

Type to search articles.